Reuters logo
9 months ago
BRIEF-Biocartis launches second liquid biopsy assay co-developed with Merck
December 7, 2016 / 6:23 AM / 9 months ago

BRIEF-Biocartis launches second liquid biopsy assay co-developed with Merck

Dec 7 (Reuters) - Biocartis Group NV :

* Launches second liquid biopsy assay - assay co-developed with Merck for detection of KRAS mutations, operating directly on 1 ml blood plasma Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below